NCT02373163 - INTERVENCION Trial | Biotech Hunter

Enrollment

166

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

March 1, 2016

Study Completion Date

June 1, 2016

Conditions

Blood Pressure, High

Interventions

DRUG

Hydrochlorothiazide

Arm: Active Comparator: Diuretic Therapy with hydrochlorothiazide (25 mg daily) taken once daily between 6 and 8 AM Arm: Active Comparator: Calcium-channel blocker Therapy with amlodipine (10 mg daily) taken once daily between 6 and 8 AM Arm: Active Comparator: Angiotensin Receptor Blocker Therapy with Telmisartan (80 mg daily) taken once daily between 6 and 8 AM

DRUG

Amlodipine

Therapy with amlodipine (10 mg daily) taken once daily between 6 and 8 AM

DRUG

Telmisartan

Therapy with Telmisartan (80 mg daily) taken once daily between 6 and 8 AM

Trial Locations (1)

Unknown

Centro de Investigacion PREVENCION, Arequipa